2025 Multiprofessional Critical Care Review: Adult Online-Congestive Heart Failure

Video Transcription

Video Summary

The presentation discusses heart failure diagnosis and management, emphasizing clinical evaluation, imaging (echocardiogram, chest X-ray, ECG), and biomarkers (BNP, troponin). Heart failure is classified by ejection fraction: reduced (<40%), mildly reduced (41-49%), and preserved (≥50%). Right heart catheterization is reserved for severe cases, as it improves outcomes by tailoring treatment based on hemodynamics. Management includes starting neurohormonal antagonists (ACE inhibitors, beta-blockers, MRAs, SGLT2 inhibitors) early in hospitalized patients, even before dose optimization. Vasodilators like nitroprusside are crucial for patients with cardiogenic shock and high systemic vascular resistance to improve perfusion. The talk highlights using pulmonary artery catheters to differentiate shock types (left, right, biventricular) via pressures, aiding precise therapy. It covers stages of shock, importance of hypoperfusion as a mortality predictor, and the synergy of combined medication for decongestion and symptom relief. Overall, individualized treatment guided by hemodynamic data optimizes heart failure outcomes, especially in critically ill patients.

Keywords

heart failure diagnosis

clinical evaluation

echocardiogram

biomarkers BNP troponin

neurohormonal antagonists

pulmonary artery catheter

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.